PHERAZINE DM Drug Patent Profile
✉ Email this page to a colleague
When do Pherazine Dm patents expire, and when can generic versions of Pherazine Dm launch?
Pherazine Dm is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in PHERAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
Summary for PHERAZINE DM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHERAZINE DM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PHERAZINE DM
US Patents and Regulatory Information for PHERAZINE DM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Halsey | PHERAZINE DM | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 088913-001 | Mar 2, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |